Alcoholic Hepatitis
Alcoholic hepatitis is an inflammation of the liver due to excessive alcohol intake, often following at least 10 years of heavy drinking. It presents with symptoms like jaundice, abdominal pain, and encephalopathy, and can lead to severe liver damage or cirrhosis if drinking continues.
Health Outcomes
- Aggravated Liver Injury
- Alleviated Liver Injury
- Altered Metabolite Profile
- Altered Plasma Metabolite Levels
- Attenuated Hepatic Disorders
- Changed Albumin Level
- Changes in Liver Fibrosis Markers
- Elevated Acetic Acid Levels
- Elevated Alkaline Phosphatase Levels
- Elevated Hepatic Enzyme Levels
- Elevated Serum Alanine Aminotransferase Levels
- Elevated Serum Aspartate Aminotransferase Levels
- Enhanced Active Metabolite Levels
- Enhanced Antioxidant Enzyme Activity
- Enhanced Antioxidant Metabolism
- Enhanced Liver Protection
- Improved Acute Liver Injury
- Improved Alcohol Metabolism
- Improved Alcohol-Associated Liver Disease Parameters
- Improved Alcohol-induced Liver Injury
- Improved Anti-Oxidative Effects
- Improved Antioxidant Enzyme Levels
- Improved Child-Pugh Score
- Improved Child-Pugh Scores
- Improved Chronic Alcohol-Induced Liver Injury
- Improved Detoxification
- Improved Enzyme Levels (ADH, ALDH)
- Improved Glutathione Level
- Improved Hepatic Damage
- Improved Hepatic Disease
- Improved Hepatic Function
- Improved Hepatic Oxidative Stress
- Improved Hepatopancreas Health
- Improved Liver Biomarkers
- Improved Liver Disease Biomarkers
- Improved Liver Enzyme Activity
- Improved Liver Enzyme Function
- Improved Liver Function
- Improved Liver Function (γ-glutamyltranspeptidase)
- Improved Liver Histology
- Improved Liver Metabolic Pathways
- Improved Liver Morphology
- Improved Liver Regeneration
- Improved Phagocytic Activity of Macrophages
- Improved Protein Synthesis in Liver
- Improvement in Alcoholic Liver Disease
- Increased ALDH Levels
- Increased Alcohol Dehydrogenase Levels in Liver
- Increased Alkaline Phosphatase Activity in Skin Mucus
- Increased Aspartate Aminotransferase Concentration
- Increased Aspartate Aminotransferase Level
- Increased Aspartate Transferase Level
- Increased Bacterial Translocation
- Increased Betaine Content
- Increased CD14+HLA-DR+ Cell Percentage in Males
- Increased Catalase Levels
- Increased Choline Level
- Increased Circulating Bile Acid Levels
- Increased Conjugated Bile Acid Levels
- Increased Cytoprotection Against Tissue Damage
- Increased DNA Damage
- Increased Degradation of Non-Assimilated Compounds
- Increased Enzyme Production
- Increased Ferritin Level
- Increased Hepatic Antioxidant Enzyme Activity
- Increased Hepatic Antioxidant Enzyme Levels
- Increased Hepatic Glutathione Content
- Increased Hepatic Glutathione Levels
- Increased Histological Damage
- Increased Hydroxy Fatty Acid Level
- Increased Liver Alcohol Metabolizing Enzyme Activity
- Increased Liver Enzyme Levels
- Increased PT/INR
- Increased Peroxidase Activity
- Increased Plasma Deconjugated Bile Acids
- Increased Plasma GLDH
- Increased Portal Endotoxin Levels
- Increased Serum Peroxidase Activity
- Increased Serum Total Bile Acid Levels
- Increased Survival Rate of Alcohol-Treated Cells
- Liver Histopathological Damage
- Lowered Serum Levels of Liver Injury Markers
- Maintained Normal Liver Function
- Modified Hepatic Inflammatory Cell Pattern
- Modulated Liver Metabolic Pathways
- No Change in Fibrosis
- No Significant Change in Aflatoxin Distribution or Metabolism
- Normalized INR
- Preserved Liver Structure
- Prevented Exacerbation of Thiamine Deficiency
- Prevented Increase in Total Bilirubin
- Prevented Liver Fibrosis
- Prevented Liver Injury
- Prevented Liver Pathway Dysregulation
- Prevention of Alcoholic Liver Disease
- Prolonged INR
- Reduced AST Levels
- Reduced Abnormal Increase in Bilirubin
- Reduced Acute Pancreatitis Severity
- Reduced Alanine Transaminase Levels
- Reduced Alcohol Consumption
- Reduced Alcohol-Induced Liver Inflammation
- Reduced Alcohol-Induced Liver Injury
- Reduced Alcohol-Induced Liver Lipid Accumulation
- Reduced Alcohol-Induced Liver Oxidative Stress
- Reduced Aminotransferase Levels
- Reduced Ammonia Levels
- Reduced Anticoagulation / Increased Warfarin Variability
- Reduced Apolipoprotein B Level
- Reduced Aspartate Aminotransferase Levels
- Reduced Aspartate Transaminase Activity
- Reduced Bile Acid Levels
- Reduced Blood Ammonia Level
- Reduced Butyrylcholinesterase Activity
- Reduced Dimethyl Sulfide Level
- Reduced Elevated Liver Enzymes
- Reduced Elevated Serum Alanine Aminotransferase (ALT)
- Reduced Endotoxin Levels
- Reduced Ferroptosis
- Reduced Fibrinogen Level
- Reduced Fibrosis Marker Levels
- Reduced GPT Level
- Reduced Globulin Level
- Reduced Glutamyl Pyruvic Transaminase Levels
- Reduced Hepatic Apoptosis
- Reduced Hepatic Damage Indices
- Reduced Hepatic Encephalopathy
- Reduced Hepatic Glycogen Levels
- Reduced Hepatic Histological Injury
- Reduced Hepatic Inflammation
- Reduced Hepatic Inflammation Markers
- Reduced Hepatic Inflammation and Oxidative Stress
- Reduced Hepatic Inflammatory Cytokines
- Reduced Hepatic Nitric Oxide Production
- Reduced Hepatic Oxidative Stress
- Reduced Hepatic Steatosis
- Reduced Hepatic Steatosis Severity
- Reduced Hepatocellular Carcinoma Recurrence
- Reduced Hepatocellular Damage
- Reduced Hepatocyte Ballooning
- Reduced Hepatocyte Necrosis
- Reduced Hepatocyte Oxidative Stress
- Reduced Hepatotoxicity
- Reduced Hepatotoxicity from Iron Oxide Nanoparticles
- Reduced Histological Damage Scores
- Reduced Histological Liver Injury
- Reduced Histological Scores
- Reduced Incidence of Abnormal Increase in Alkaline Phosphatase
- Reduced Incidence of Liver Cancer
- Reduced Lipopolysaccharide-Binding Protein
- Reduced Liver Biochemical Markers
- Reduced Liver Damage
- Reduced Liver Damage Indicators
- Reduced Liver Damage Markers Levels
- Reduced Liver Disease Progression
- Reduced Liver Disease Symptoms
- Reduced Liver Enzyme Activity
- Reduced Liver Fat Vacuolization
- Reduced Liver Fibrosis
- Reduced Liver Function
- Reduced Liver Function Indicators
- Reduced Liver Inflammation
- Reduced Liver Inflammation Fibrosis Score
- Reduced Liver Injury Indicators
- Reduced Liver Injury Marker
- Reduced Liver Lesion Severity
- Reduced Liver Oxidative Damage
- Reduced Liver Oxidative Stress Injury
- Reduced Liver Stiffness
- Reduced Liver Toxicity
- Reduced Lobular Inflammation
- Reduced Microbial Translocation to the Liver
- Reduced Pathological Changes of Liver
- Reduced Plasma Endotoxin Concentration
- Reduced Procollagen Type 1 N-terminal Propeptide Level
- Reduced Proinflammatory Bacteria
- Reduced Serum Alanine Aminotransferase Activity
- Reduced Serum Alanine Aminotransferase Levels
- Reduced Serum Gamma Glutamine Transaminase Levels
- Reduced Serum Transaminase Levels
- Reduced Serum α-1-Acid Glycoprotein Levels
- Reduced Steatohepatitis
- Reduced TNF-alpha Level
- Reduced Toxin-induced Cytotoxicity
- Reduced Urea Level
- Reduced Zinc Level
- Regulated Liver Glycerophospholipid Metabolism
- Regulated Liver Metabolite Levels
- Significant Histopathological Changes in Liver
- Stabilized Total Bilirubin Levels
- Stable Aspartate Aminotransferase Levels